These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 12715326)
1. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome. Kerr JR; Cunniffe VS; Kelleher P; Bernstein RM; Bruce IN Clin Infect Dis; 2003 May; 36(9):e100-6. PubMed ID: 12715326 [TBL] [Abstract][Full Text] [Related]
2. Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome. Attard L; Bonvicini F; Gelsomino F; Manfredi R; Cascavilla A; Viale P; Varani S; Gallinella G J Clin Virol; 2015 Jan; 62():54-7. PubMed ID: 25542471 [TBL] [Abstract][Full Text] [Related]
3. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia. Seishima M; Mizutani Y; Shibuya Y; Arakawa C Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075 [TBL] [Abstract][Full Text] [Related]
4. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112 [TBL] [Abstract][Full Text] [Related]
5. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists. Lowry SM; Brent LH; Menaldino S; Kerr JR Clin Infect Dis; 2005 Aug; 41(4):e42-4. PubMed ID: 16028146 [TBL] [Abstract][Full Text] [Related]
6. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575 [TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325 [TBL] [Abstract][Full Text] [Related]
8. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Kerr JR; Gough J; Richards SC; Main J; Enlander D; McCreary M; Komaroff AL; Chia JK J Gen Virol; 2010 Apr; 91(Pt 4):893-7. PubMed ID: 20007355 [TBL] [Abstract][Full Text] [Related]
9. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy. Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805 [TBL] [Abstract][Full Text] [Related]
11. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. Kerr JR; Cunniffe VS; Kelleher P; Coats AJ; Mattey DL J Med Virol; 2004 Sep; 74(1):147-55. PubMed ID: 15258981 [TBL] [Abstract][Full Text] [Related]
12. Increase in B19 viral load prior to relapse of anaemia in an AIDS patient with persistent B19 infection. Hung CC; Lee KL; Chen MY J Infect; 2001 Aug; 43(2):150-2. PubMed ID: 11676524 [TBL] [Abstract][Full Text] [Related]
13. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease. Katragadda L; Shahid Z; Restrepo A; Muzaffar J; Alapat D; Anaissie E Transpl Infect Dis; 2013 Aug; 15(4):354-60. PubMed ID: 23578205 [TBL] [Abstract][Full Text] [Related]
20. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection. Tang JW; Lau JS; Wong SY; Cheung JL; Chan CH; Wong KF; Wong A; Chan PK J Med Virol; 2007 Sep; 79(9):1401-5. PubMed ID: 17607784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]